Register      Login
Animal Production Science Animal Production Science Society
Food, fibre and pharmaceuticals from animals
RESEARCH ARTICLE

Protective effects of pre-treatment with exogenous porcine glucagon-like peptide-2 and its microspheres of piglets with lipopolysaccharide-induced intestinal inflammation

Jie Wu A , Keke Qi A and Ziwei Xu https://orcid.org/0000-0003-3945-7000 A *
+ Author Affiliations
- Author Affiliations

A Institute of Animal Science, Zhejiang Academy of Agricultural Sciences, Hangzhou, Zhejiang 310021, China.

* Correspondence to: zjsnkyxzw@163.com

Handling Editor: Sathya Velmurugan

Animal Production Science 63(1) 51-58 https://doi.org/10.1071/AN22218
Submitted: 6 June 2022  Accepted: 25 August 2022   Published: 23 September 2022

© 2023 The Author(s) (or their employer(s)). Published by CSIRO Publishing

Abstract

Context: Glucagon-like peptide-2 (GLP-2) is an intestinotrophic growth hormone that can accelerate intestinal development and recovery from injury. However, the half-life of GLP-2 is short, thus it must be administered frequently. Moreover, its effects during weaning are unclear.

Aims: We tested the effects of porcine GLP-2 (pGLP-2) and pGLP-2 microspheres on lipopolysaccharide (LPS)-induced intestinal inflammation in weaning piglets.

Methods: Eighteen female weaning piglets aged 21 days (5.38 ± 0.72 kg initial bodyweight) were randomly assigned to three treatment groups: (1) control, (2) GLP-2, and (3) GLP-2 microsphere (MS) group. Control piglets were injected intraperitoneally with 3 mL of saline solution from Days 1 to 7, GLP-2 piglets were injected intraperitoneally with 100 μg pGLP-2/kg bodyweight from Days 1 to 7, and MS piglets were injected intraperitoneally with 200 mg GLP-2 microspheres on Day 1 and with 3 mL saline solution from Days 2 to 7. On Day 8, all piglets were injected with 100 μg LPS/kg bodyweight.

Key results: Piglets in the GLP-2 and MS groups showed markedly increased average daily weight gain on Day 7, decreased serum myeloperoxidase, LPS and keratinocyte growth factor levels, and increased serum interleukin-10 levels compared with the control group. In addition, the GLP-2 group showed decreased myeloperoxidase content in the duodenum and ileum, and reduced caspase-3 activity in the duodenum and jejunum, whereas MS piglets showed decreased myeloperoxidase levels and suppressed caspase-3 activity in the duodenum and jejunum. Moreover, administration of pGLP-2 or pGLP-2 microspheres resulted in decreased interleukin-8 and interferon-γ mRNA expression levels in the jejunum, as compared with the control group.

Conclusions: Our results indicated that pGLP-2 promotes growth, and ameliorates LPS-induced serum and intestinal inflammatory responses in piglets. Furthermore, pGLP-2 microspheres can achieve similar therapeutic effects as pGLP-2 under the premise of fewer injections.

Implications: pGLP-2 microspheres have considerable potential for the treatment of weaning-induced intestinal inflammation in piglets.

Keywords: body weight, intestinal inflammation, lipopolysaccharide, microspheres, mRNA expression, piglets, porcine glucagon-like peptide-2, serum.


References

Alters SE, McLaughlin B, Spink B, Lachinyan T, Wang C-W, Podust V, Schellenberger V, Stemmer WPC (2012) GLP2-2G-XTEN: a pharmaceutical protein with improved serum half-life and efficacy in a rat Crohn’s disease model. PLoS ONE 7, e50630
GLP2-2G-XTEN: a pharmaceutical protein with improved serum half-life and efficacy in a rat Crohn’s disease model.Crossref | GoogleScholarGoogle Scholar |

Anderson JM, Shive MS (2012) Biodegradation and biocompatibility of PLA and PLGA microspheres. Advanced Drug Delivery Reviews 64, 72–82.
Biodegradation and biocompatibility of PLA and PLGA microspheres.Crossref | GoogleScholarGoogle Scholar |

Boushey RP, Yusta B, Drucker DJ (1999) Glucagon-like peptide 2 decreases mortality and reduces the severity of indomethacin-induced murine enteritis. American Journal of Physiology-Endocrinology and Metabolism 277, E937–E947.
Glucagon-like peptide 2 decreases mortality and reduces the severity of indomethacin-induced murine enteritis.Crossref | GoogleScholarGoogle Scholar |

Burrin DG, Stoll B, Guan X, Cui L, Chang X, Holst JJ (2005) Glucagon-like peptide 2 dose-dependently activates intestinal cell survival and proliferation in neonatal piglets. Endocrinology 146, 22–32.
Glucagon-like peptide 2 dose-dependently activates intestinal cell survival and proliferation in neonatal piglets.Crossref | GoogleScholarGoogle Scholar |

Chance WT, Sheriff S, McCarter F, Ogle C (2001) Glucagon-like peptide-2 stimulates gut mucosal growth and immune response in burned rats. Journal of Burn Care & Rehabilitation 22, 136–143.
Glucagon-like peptide-2 stimulates gut mucosal growth and immune response in burned rats.Crossref | GoogleScholarGoogle Scholar |

Deng QH, Jia G, Zhao H, Chen ZL, Chen XL, Liu GM, Wang KN (2016) The prolonged effect of glucagon-like peptide 2 pretreatment on growth performance and intestinal development of weaned piglets. Journal of Animal Science and Biotechnology 7, 28
The prolonged effect of glucagon-like peptide 2 pretreatment on growth performance and intestinal development of weaned piglets.Crossref | GoogleScholarGoogle Scholar |

Guan L-L, Gong D-Z, Tian N, Zou Y (2005) Uncoupling protein 2 involved in protection of glucagon-like peptide 2 in small intestine with ischemia-reperfusion injury in mice. Digestive Diseases & Sciences 50, 554–560.
Uncoupling protein 2 involved in protection of glucagon-like peptide 2 in small intestine with ischemia-reperfusion injury in mice.Crossref | GoogleScholarGoogle Scholar |

Heo JM, Opapeju FO, Pluske JR, Kim JC, Hampson DJ, Nyachoti CM (2013) Gastrointestinal health and function in weaned pigs: a review of feeding strategies to control post-weaning diarrhoea without using in-feed antimicrobial compounds. Journal of Animal Physiology and Animal Nutrition 97, 207–237.
Gastrointestinal health and function in weaned pigs: a review of feeding strategies to control post-weaning diarrhoea without using in-feed antimicrobial compounds.Crossref | GoogleScholarGoogle Scholar |

Isbil-Buyukcoskun N, Cam B, Gulec Suyen G, Ozluk K (2018) Effects of intracerebroventricularly injected glucagon-like peptide-2 on ethanol-induced gastric mucosal damage in rats. Endocrine Research 43, 220–227.
Effects of intracerebroventricularly injected glucagon-like peptide-2 on ethanol-induced gastric mucosal damage in rats.Crossref | GoogleScholarGoogle Scholar |

Ivory CPA, Wallace LE, McCafferty D-M, Sigalet DL (2008) Interleukin-10-independent anti-inflammatory actions of glucagon-like peptide 2. American Journal of Physiology-Gastrointestinal and Liver Physiology 295, G1202–G1210.
Interleukin-10-independent anti-inflammatory actions of glucagon-like peptide 2.Crossref | GoogleScholarGoogle Scholar |

Jeppesen PB (2005) Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients. Gut 54, 1224–1231.
Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients.Crossref | GoogleScholarGoogle Scholar |

Jeppesen PB, Pertkiewicz M, Messing B, Iyer K, Seidner DL, O’keefe SJD, Forbes A, Heinze H, Joelsson B (2012) Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure. Gastroenterology 143, 1473–1481.e3.
Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure.Crossref | GoogleScholarGoogle Scholar |

Lai SW, de Heuvel E, Wallace LE, Hartmann B, Holst JJ, Brindle ME, Chelikani PK, Sigalet DL (2017) Effects of exogenous glucagon-like peptide-2 and distal bowel resection on intestinal and systemic adaptive responses in rats. PLoS ONE 12, e0181453
Effects of exogenous glucagon-like peptide-2 and distal bowel resection on intestinal and systemic adaptive responses in rats.Crossref | GoogleScholarGoogle Scholar |

Lallès J-P, Bosi P, Smidt H, Stokes CR (2007) Weaning – a challenge to gut physiologists. Livestock Science 108, 82–93.
Weaning – a challenge to gut physiologists.Crossref | GoogleScholarGoogle Scholar |

Lei Q, Bi J, Chen H, Tian F, Gao X, Li N, Wang X (2018) Glucagon-like peptide-2 improves intestinal immune function and diminishes bacterial translocation in a mouse model of parenteral nutrition. Nutrition Research 49, 56–66.
Glucagon-like peptide-2 improves intestinal immune function and diminishes bacterial translocation in a mouse model of parenteral nutrition.Crossref | GoogleScholarGoogle Scholar |

Ørskov C, Hartmann B, Poulsen SS, Thulesen J, Hare KJ, Holst JJ (2005) GLP-2 stimulates colonic growth via KGF, released by subepithelial myofibroblasts with GLP-2 receptors. Regulatory Peptides 124, 105–112.
GLP-2 stimulates colonic growth via KGF, released by subepithelial myofibroblasts with GLP-2 receptors.Crossref | GoogleScholarGoogle Scholar |

Pedersen NB, Hjollund KR, Johnsen AH, Ørskov C, Rosenkilde MM, Hartmann B, Holst JJ (2008) Porcine glucagon-like peptide-2: structure, signaling, metabolism and effects. Regulatory Peptides 146, 310–320.
Porcine glucagon-like peptide-2: structure, signaling, metabolism and effects.Crossref | GoogleScholarGoogle Scholar |

Qi K-K, Wu J, Xu Z-W (2014) Effects of PEGylated porcine glucagon-like peptide-2 therapy in weaning piglets challenged with lipopolysaccharide. Peptides 58, 7–13.
Effects of PEGylated porcine glucagon-like peptide-2 therapy in weaning piglets challenged with lipopolysaccharide.Crossref | GoogleScholarGoogle Scholar |

Qi KK, Wu J, Deng B, Li YM, Xu ZW (2015) PEGylated porcine glucagon-like peptide-2 improved the intestinal digestive function and prevented inflammation of weaning piglets challenged with LPS. Animal 9, 1481–1489.
PEGylated porcine glucagon-like peptide-2 improved the intestinal digestive function and prevented inflammation of weaning piglets challenged with LPS.Crossref | GoogleScholarGoogle Scholar |

Qi KK, Wu J, Wen Jun Z, Bo D, Xu ZW (2020) Catch-up growth in intrauterine growth-restricted piglets associated with the restore of pancreatic and intestinal functions via porcine glucagon-like peptide-2 microspheres. Archives of Animal Nutrition 74, 462–475.
Catch-up growth in intrauterine growth-restricted piglets associated with the restore of pancreatic and intestinal functions via porcine glucagon-like peptide-2 microspheres.Crossref | GoogleScholarGoogle Scholar |

Sigalet DL, Wallace L, De Heuval E, Sharkey KA (2010) The effects of glucagon-like peptide 2 on enteric neurons in intestinal inflammation. Neurogastroenterology & Motility 22, 1318–e350.
The effects of glucagon-like peptide 2 on enteric neurons in intestinal inflammation.Crossref | GoogleScholarGoogle Scholar |

Sigalet DL, de Heuvel E, Wallace L, Bulloch E, Turner J, Wales PW, Nation P, Wizzard PR, Hartmann B, Assad M, Holst JJ (2014) Effects of chronic glucagon-like peptide-2 therapy during weaning in neonatal pigs. Regulatory Peptides 188, 70–80.
Effects of chronic glucagon-like peptide-2 therapy during weaning in neonatal pigs.Crossref | GoogleScholarGoogle Scholar |

Thymann T, Le Huërou-Luron I, Petersen YM, Hedemann MS, Elinf J, Jensen BB, Holst JJ, Hartmann B, Sangild PT (2014) Glucagon-like peptide 2 treatment may improve intestinal adaptation during weaning. Journal of Animal Science 92, 2070–2079.
Glucagon-like peptide 2 treatment may improve intestinal adaptation during weaning.Crossref | GoogleScholarGoogle Scholar |

Washizawa N, Gu LH, Gu L, Openo KP, Jones DP, Ziegler TR (2004) Comparative effects of glucagon-like peptide-2 (GLP-2), growth hormone (GH), and keratinocyte growth factor (KGF) on markers of gut adaptation after massive small bowel resection in rats. Journal of Parenteral and Enteral Nutrition 28, 399–409.
Comparative effects of glucagon-like peptide-2 (GLP-2), growth hormone (GH), and keratinocyte growth factor (KGF) on markers of gut adaptation after massive small bowel resection in rats.Crossref | GoogleScholarGoogle Scholar |

Wu J, Qi K, Xu Z, Wan J (2015) Glucagon-like peptide-2-loaded microspheres as treatment for ulcerative colitis in the murine model. Journal of Microencapsulation 32, 598–607.
Glucagon-like peptide-2-loaded microspheres as treatment for ulcerative colitis in the murine model.Crossref | GoogleScholarGoogle Scholar |

Wu J, Qi KK, Xu ZW (2016) Porcine glucagon-like peptide-2 microspheres ameliorate inflammation in lipopolysaccharide-challenged weaning piglets. Journal of Animal Science 94, 5286–5294.
Porcine glucagon-like peptide-2 microspheres ameliorate inflammation in lipopolysaccharide-challenged weaning piglets.Crossref | GoogleScholarGoogle Scholar |

Yu C, Jia G, Jiang Y, Deng Q, Chen Z, Xu Z, Chen X, Wang K (2014) Effect of glucagon-like peptide 2 on tight junction in jejunal epithelium of weaned pigs though MAPK signaling pathway. Asian-Australasian Journal of Animal Sciences 27, 733–742.
Effect of glucagon-like peptide 2 on tight junction in jejunal epithelium of weaned pigs though MAPK signaling pathway.Crossref | GoogleScholarGoogle Scholar |